Riverview Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $653K | Sell |
2,593
-600
| -19% | -$129K | 0.78% | 21 |
|
|
2026
Q1 | $694K | Hold |
3,193
| – | – | 0.86% | 21 |
|
|
2025
Q4 | $730K | Hold |
3,193
| – | – | 0.88% | 18 |
|
|
2025
Q3 | $739K | Hold |
3,193
| – | – | 0.89% | 20 |
|
|
2025
Q2 | $593K | Sell |
3,193
-3,013
| -49% | -$560K | 0.74% | 21 |
|
|
2025
Q1 | $1.3M | Sell |
6,206
-1,093
| -15% | -$212K | 1.28% | 14 |
|
|
2024
Q4 | $1.3M | Sell |
7,299
-45
| -0.6% | -$8.27K | 1.18% | 18 |
|
|
2024
Q3 | $1.45M | Buy |
7,344
+30
| +0.4% | +$5.6K | 1.27% | 16 |
|
|
2024
Q2 | $1.25M | Sell |
7,314
-360
| -5% | -$59.6K | 1.19% | 19 |
|
|
2024
Q1 | $1.4M | Hold |
7,674
| – | – | 1.08% | 18 |
|
|
2023
Q4 | $1.19M | Buy |
7,674
+39
| +0.5% | +$5.69K | 1.21% | 21 |
|
|
2023
Q3 | $1.14M | Hold |
7,635
| – | – | 1.01% | 21 |
|
|
2023
Q2 | $1.03M | Sell |
7,635
-180
| -2% | -$26.4K | 0.93% | 21 |
|
|
2023
Q1 | $1.25M | Hold |
7,815
| – | – | 1.14% | 18 |
|
|
2022
Q4 | $1.26M | Sell |
7,815
-183
| -2% | -$28.1K | 1.2% | 15 |
|
|
2022
Q3 | $1.07M | Sell |
7,998
-189
| -2% | -$27.1K | 1.04% | 16 |
|
|
2022
Q2 | $1.25M | Buy |
8,187
+249
| +3% | +$38K | 1.09% | 18 |
|
|
2022
Q1 | $1.29M | Buy |
7,938
+786
| +11% | +$114K | 0.95% | 19 |
|
|
2021
Q4 | $968K | Buy |
7,152
+726
| +11% | +$85.8K | 0.57% | 26 |
|
|
2021
Q3 | $693K | Buy |
6,426
+756
| +13% | +$86.4K | 0.73% | 30 |
|
|
2021
Q2 | $639K | Sell |
5,670
-320
| -5% | -$36K | 0.68% | 31 |
|
|
2021
Q1 | $648K | Hold |
5,990
| – | – | 0.72% | 30 |
|
|
2020
Q4 | $642K | Sell |
5,990
-125
| -2% | -$12K | 0.71% | 30 |
|
|
2020
Q3 | $536K | Sell |
6,115
-45
| -0.7% | -$4.24K | 0.62% | 34 |
|
|
2020
Q2 | $605K | Sell |
6,160
-320
| -5% | -$28.2K | 0.59% | 33 |
|
|
2020
Q1 | $494K | Sell |
6,480
-3,700
| -36% | -$315K | 0.47% | 35 |
|
|
2019
Q4 | $902K | Sell |
10,180
-583
| -5% | -$48.4K | 0.61% | 31 |
|
|
2019
Q3 | $815K | Sell |
10,763
-4,962
| -32% | -$340K | 0.57% | 30 |
|
|
2019
Q2 | $1.14M | Sell |
15,725
-703
| -4% | -$55.3K | 0.8% | 22 |
|
|
2019
Q1 | $1.32M | Buy |
16,428
+36
| +0.2% | +$2.94K | 1% | 18 |
|
|
2018
Q4 | $1.51M | Buy |
+16,392
| New | +$1.44M | 1.18% | 15 |
|
Other funds holding ABBV
Riverview Trust Company's ABBV Position: Q2 2026 in Review
Riverview Trust Company reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $129K and leaving 2,593 shares worth $653K. The position accounts for 0.78% of the portfolio, ranked #21.
Riverview Trust Company first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.51M in Q4 2018. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Riverview Trust Company held 2,593 shares of AbbVie worth $653K as of Q2 2026.
- Riverview Trust Company sold 600 AbbVie shares in Q2 2026, an estimated $129K.
- AbbVie made up 0.78% of Riverview Trust Company's portfolio in Q2 2026, its #21 holding.
- Riverview Trust Company first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Riverview Trust Company's AbbVie position peaked at $1.51M in Q4 2018.
- 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Riverview Trust Company's 13F filing for Q2 2026, filed 3 Aug 2026.